Advertisement

Topics

Oy Faron Pharmaceuticals LTD. Company Profile

18:06 EST 20th November 2017 | BioPortfolio

Faron Pharmaceuticals Ltd. ("Faron") is a drug discovery and drug development service company. It was founded by a group of R&D professionals, and joined by business and legal advisors with excellent track records.Faron has very good connections to research groups at non-commercial environments, e.g. at universities, in which the majority of new biomedical innovations are made nowadays. Faron's strategy is to become a significant value adding -partner for research group -based projects as well as for all commercial partners utilizing this innovation channel. Faron also develops its own projects, and some proprietary IP-rights have been transferred to the Company at its inception. Current projects focus on cancer, inflammation and trauma.

Location

Itäinen Pitkäkatu 4 B,
Pharma
Turku
FIN-20520
Finland

Contact

Phone: 358 2 478 8400
Fax: 358 2 478 8411
Email: info@faronpharmaceuticals.com


News Articles [466 Associated News Articles listed on BioPortfolio]

Faron Pharmaceuticals Oy: Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine® following completion of European and Japanese Phase III studies

Faron Pharmaceuticals Ltd("Faron" or the "Company") Faron announces that US FDA proposes proceeding directly to BLA submission for Traumakine® following completion of European and Japane...

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been oversubscribed, which reflects the excitement around its drug candidate, Traumakine. By securing £10M, Faron matches its IPO ...

Following FDA encouragement, Faron’s orphan drug gets UK special designation

Faron Pharmaceuticals has been granted a Promising Innovative Medicines (PIM) designation in the UK for its lead product Traumakine, currently in phase 3 trials for Acute Respiratory Distress Syndrome...

'Promising' Status For Faron's Traumakine In UK Opens Possibilities For Early Access, Pricing Negotiations

The UK regulator has granted a "promising designation" to Faron Pharmaceuticals' Traumakine acute respiratory distress syndrome treatment, which means the...   

Faron receives IDMC recommendation to continue Phase III ARDS trial

Finland-based biopharmaceutical firm Faron Pharmaceuticals has received recommendation from the Independent Data Monitoring Committee (IDMC) to continue its Phase III clinical trial (INTEREST) of Trau...

Faron Pharma to provide drug compassionate use of drug; data monitors green light study as it moves into its final few months

Faron Pharmaceuticals Ltd (LON:FARN) said it is planning to provide its lead drug on a compassionate use basis once its phase III clinical trial has concluded. The study, codenamed INTEREST, should ...

Faron Pharma to provide drug on a compassionate use basis; data monitors green light study as it moves into its final few months

Faron Pharmaceuticals Ltd (LON:FARN) said it is planning to provide its lead drug on a compassionate use basis once its phase III clinical trial has concluded. The study, codenamed INTEREST, should ...

Faron Pharmaceuticals Oy: Interim Results for the six months ended 30 June 2017

Faron Pharmaceuticals Ltd("Faron" or the "Company") Interim Results for the six months ended 30 June 2017 INTEREST Phase III Traumakine® trial patient recruitment to complete in Q4...

Drugs and Medications [270 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]

EYEWASH STATION ADDITIVE CONCENTRATE

PubMed Articles [120 Associated PubMed Articles listed on BioPortfolio]

Announcing the 2017 Pharmaceuticals Travel Award for Young Post-Doctoral Researchers.

Last year, for the first time in its history, our Journal was able to offer a travel grant of 800 CHF to a young researcher in the field of medicinal chemistry.

Suspended solids moderate the degradation and sorption of waste water-derived pharmaceuticals in estuarine waters.

This study focuses on the fate of pharmaceuticals discharged into an estuarine environment, particularly into the Turbidity Maximum Zone (TMZ). Batch experiments were set up to investigate the factors...

Chiral pharmaceuticals: A review on their environmental occurrence and fate processes.

More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the same pharmaceutical have identical physicochemical properties, but may exhibit differences in pharmacokinetics,...

Comparative study on pharmaceuticals adsorption in reclaimed water desalination concentrate using biochar: Impact of salts and organic matter.

The synergistic impact of salts and organic matter on adsorption of ibuprofen and sulfamethoxazole by three types of biochar and an activated carbon was investigated using reclaimed water reverse osmo...

Effects of exposure to pharmaceuticals (diclofenac and carbamazepine) spiked sediments in the midge, Chironomus riparius (Diptera, Chironomidae).

Human and veterinary pharmaceuticals and degradation products are continuously introduced into the environment. To date, there is a lack of information about the effects of pharmaceuticals in spiked t...

Clinical Trials [206 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1287 Associated Companies listed on BioPortfolio]

Oy Faron Pharmaceuticals LTD.

Faron Pharmaceuticals Ltd. ("Faron") is a drug discovery and drug development service company. It was founded by a group of R&D professionals, and joined by business and legal advisors with excellent ...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

Serenity Pharmaceuticals

Founded in 2007 and located in Milford, Pennsylvania, Serenity Pharmaceuticals is focused on developing products that address urinary conditions that impact the health and well-be...

Avanir Pharmaceuticals

AVANIR Pharmaceuticals, formerly LIDAK Pharmaceuticals, is a development stage company organized to discover, develop, and market novel therapeutic products to treat human diseases.

More Information about "Oy Faron Pharmaceuticals LTD." on BioPortfolio

We have published hundreds of Oy Faron Pharmaceuticals LTD. news stories on BioPortfolio along with dozens of Oy Faron Pharmaceuticals LTD. Clinical Trials and PubMed Articles about Oy Faron Pharmaceuticals LTD. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oy Faron Pharmaceuticals LTD. Companies in our database. You can also find out about relevant Oy Faron Pharmaceuticals LTD. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record